Nunki Hassan

Highly committed postdoctoral researcher over seven years of experience in cancer research, which includes novel and emerging technologies based on biochemistry, molecular and cellular biology investigating cancer patient profiles. Utilising novel technologies such as single cell RNA-sequencing uncovered key genetic profiles of acute myeloid leukemia (AML) patients to select effective targeted therapies. Extensive research and teaching experience in investigating molecular mechanisms and genetic variation in patients to determine and tailor effective therapeutic strategies for better clinical outcomes in AML.